City page
Kaunas biotech and pharma directory
This page shows why the city matters, which categories are strongest there, and which compliance or quality markers are already visible in public evidence.
Where does this city read strongest?
Manufacturing (2), CRO (1), and Diagnostics (1). Most visible records: Bious Labs, LSMU Kaunas Clinics Biobank (Human Biological Resources Centre), and UAB Exolitus.
Which standards and public evidence are already visible?
ISO-13485 (1). Latest review: 24 April 2026. Review cycle: April 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Kaunas.
By category
Kaunas by category
Jump into a category page filtered to this country only.
Full list
Kaunas biotech and pharma directory
8 city records currently match the active filter.
Current review cycle
Bious Labs
KaunasLithuaniaManufacturing
Kaunas life-science company merging solvent-free and solvent-based electrospinning with 3D printing to produce 3D cell-culture scaffolds for research and biomaterial applications.
- Lead
- Edvinas KruglyManaging Director
- Scale
- Industrial biomaterial manufacturing
Current review cycle
LSMU Kaunas Clinics Biobank (Human Biological Resources Centre)
KaunasLithuaniaResearch
Lithuanian University of Health Sciences (LSMU) biobank at Kaunas Clinics operating as one of four national BioBank repositories for solid tissue, liquid tissue, live tissue, and health information database samples.
- Lead
- Dalia PangonyteProfessor and BioBank Lead, LSMU
- Scale
- National biobanking operations
Current review cycle
UAB Exolitus
KaunasLithuaniaBiotech
Kaunas exosome-manufacturing biotech (LSMU spin-off founded in 2020) developing patented stimulated immune-cell exosome therapies targeting glioblastoma and cosmeceutical applications, certified A-class by Okredo and Creditinfo.
- Lead
- Aiste JekabsoneChief Executive Officer
- Scale
- Exosome manufacturing
Current review cycle
Vilimed
KaunasLithuaniaMedical Device
Kaunas medical-device startup producing the CE-marked VILIM ball, a vibration-based hand-tremor reduction device using AI-adaptive algorithms, operating from Kaunas Science and Technology Park.
- Lead
- Mantas VenslauskasChief Executive Officer and Co-Founder
- Scale
- Medical-device commercialization
Current review cycle
Genomika
KaunasLithuaniaGenomics
Kaunas applied-biotechnology research company providing genomics, bioinformatics, wet-lab execution, experimental design, and DNA-storage related development services.
- Lead
- Mantas SimutisChief Executive Officer
- Scale
- Applied genomics and biotechnology services platform
Current review cycle
Ligence
KaunasLithuaniaDiagnostics
Kaunas echocardiography-analysis and clinical-AI platform delivering MDR-certified heart-ultrasound reporting workflows from Lithuania.
- Lead
- Arnas KaruzasChief Executive Officer
- Scale
- Clinical software platform for echocardiography providers
Current review cycle
Biomapas
KaunasLithuaniaCRO
Kaunas-headquartered integrated pharmaceutical-services platform spanning clinical trials, pharmacovigilance, regulatory affairs, and medical information.
- Lead
- Xavier DuburcqChief Executive Officer
- Scale
- Pan-European clinical-services network
Current review cycle
Aconitum
KaunasLithuaniaManufacturing
Kaunas pharmaceutical and botanical-products manufacturer with a long-running formulation, extraction, and quality-control base serving the Lithuanian market.
- Lead
- Rima BalanaškienėFounder and Chief Executive Officer
- Scale
- Regional pharmaceutical manufacturing
Related briefs
Briefs that mention Kaunas
Baltic CRO & Clinical Trial Landscape 2026: Lithuania, Latvia, Estonia
A practical map of the Baltic clinical research organisation landscape — Biomapas, Cureline Baltic, Inpharmatis, Asper Biogene, BioCC — and why Lithuania, Latvia, and Estonia are a credible nearshore option for EU-regulated clinical trials in 2026.
Open briefBaltic Biotech Landscape 2026: Lithuania, Latvia, Estonia
A practical map of the Baltic biotech and pharma landscape in 2026 — 74 operators across Lithuania, Latvia, and Estonia, organised by city, category, and what each actually does in the European supply chain.
Open briefEuropean Genomics & Sequencing 2026: NGS, CRISPR, NIPT, Single-Cell
A practical map of the European genomics and sequencing sector in 2026 — Estonian Genome Center, CasZyme CRISPR-Cas, Blueprint Genetics NGS diagnostics, CeGaT, Asper Biogene, plus the Baltic + Nordic single-cell and NIPT layer.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.